PMV Pharmaceuticals has announced encouraging interim findings from the phase 2 portion of its PYNNACLE trial, which is evaluating...
Lire la suiteThe cola wars are entering a new phase – one where taste meets gut health. PepsiCo has announced the...
Lire la suiteLundbeck has presented compelling new clinical data on its migraine therapy eptinezumab at the 2025 International Headache Congress (IHC)...
Lire la suiteJason’s Sourdough, the UK’s number one sourdough brand, has taken a bold step forward with the launch of its...
Lire la suiteAlzeCure Pharma has presented compelling new clinical data on its lead pain candidate, ACD440, at the NeuPSIG 2025 international...
Lire la suiteResolution Therapeutics has announced a major step forward in the fight against end-stage liver disease, with the first patient...
Lire la suite